Heron Therapeutics Inc ((HRTX)) has held its Q3 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2025 Earnings Call Transcript August 8, 2025 Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $-0.01.
Except as required by law, Heron assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes and does not intend to do so. And with that, I would now ...
Good day, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2025 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...
Image source: The Motley Fool. Heron Therapeutics (NASDAQ:HRTX) delivered operational and financial milestones, including full-year adjusted EBITDA above guidance and net product revenue gains led by ...
Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.01333. Operator: Good day, and thank you for standing by. Welcome to the Heron Therapeutics ...
Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $-0.01. Operator: Thank you for standing by, and welcome to the Heron Therapeutics Second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results